Availability of exome sequence data

As part of the Whole Exome Sequencing Consortium, during their approved exclusive access period, a collaboration between Abbvie, Biogen and Pfizer has created a browsable resource linking rare protein-coding variants to human health and disease. This resource is now publicly accessible and provides access to association summary statistics arising from analyses of the initial 300k sequenced exomes.

With agreement of these Consortium members, an accompanying manuscript has been temporarily withdrawn at UK Biobank’s request. It should be noted that the results supporting this manuscript remain valid and can be found on this browser at https://genebass.org. The full manuscript will be re-uploaded after the underlying exome data have also been made available to all approved researchers in September 2021.